Literature DB >> 25104043

Elevated parathyroid hormone, but not vitamin D deficiency, is associated with increased risk of heart failure in older men with and without cardiovascular disease.

S Goya Wannamethee1, Paul Welsh2, Olia Papacosta2, Lucy Lennon2, Peter H Whincup2, Naveed Sattar2.   

Abstract

BACKGROUND: Hyperparathyroidism and low vitamin D status have been implicated in the pathogenesis of heart failure (HF). We examined the prospective associations between parathyroid hormone (PTH), circulating 25-hydroxyvitamin D, and markers of mineral metabolism and risk of incident HF in older men with and without established cardiovascular disease. METHODS AND
RESULTS: Prospective study of 3731 men aged 60 to 79 years with no prevalent HF followed up for a mean period of 13 years, in whom there were 287 incident HF cases. Elevated PTH (≥55.6 pg/mL; top quarter) was associated with significantly higher risk of incident HF after adjustment for lifestyle characteristics, diabetes mellitus, blood lipids, blood pressure, lung function, heart rate, renal dysfunction, atrial fibrillation, forced expiratory volume in 1 second, and C-reactive protein (hazards ratio, 1.66; 95% confidence interval, 1.30-2.13). The increased risk was seen in both men with and without previous myocardial infarction or stroke (hazards ratio, 1.72; 95% confidence interval, 1.07-2.76; hazards ratio, 1.70; 95% confidence interval, 1.25-2.30, respectively). Elevated PTH was significantly associated with N-terminal probrain natriuretic peptide, a marker of left ventricular wall stress. By contrast, 25-hydroxyvitamin D and other markers of mineral metabolism including serum calcium and phosphate showed no significant association with incident HF after adjustment for age.
CONCLUSIONS: Elevated PTH, but not 25-hydroxyvitamin D or other markers of mineral metabolism, is associated with increased risk of HF in both older men with and without myocardial infarction/stroke. This increased risk was not explained by its association with known risk factors for HF. Further studies are now needed to elucidate the mechanisms underlying this association.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  heart failure; parathyroid hormone; vitamin D

Mesh:

Substances:

Year:  2014        PMID: 25104043     DOI: 10.1161/CIRCHEARTFAILURE.114.001272

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  37 in total

1.  Birth month affects lifetime disease risk: a phenome-wide method.

Authors:  Mary Regina Boland; Zachary Shahn; David Madigan; George Hripcsak; Nicholas P Tatonetti
Journal:  J Am Med Inform Assoc       Date:  2015-06-02       Impact factor: 4.497

Review 2.  Epidemiologic insights on the role of fibroblast growth factor 23 in cardiovascular disease.

Authors:  Julia J Scialla
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-05       Impact factor: 2.894

3.  Secondary hyperparathyroidism prevalence and prognostic role in elderly males with heart failure.

Authors:  G Loncar; B Bozic; N Cvetinovic; H-D Dungen; M Lainscak; S von Haehling; W Doehner; Z Radojicic; B Putnikovic; T Trippel; V Popovic
Journal:  J Endocrinol Invest       Date:  2016-10-13       Impact factor: 4.256

Review 4.  The Endocrine Role of Bone in Cardiometabolic Health.

Authors:  Rosemary DeLuccia; May Cheung; Rohit Ramadoss; Abeer Aljahdali; Deeptha Sukumar
Journal:  Curr Nutr Rep       Date:  2019-09

5.  Low vitamin D status associated with dilated cardiomyopathy.

Authors:  Veli Polat; Evin Bozcali; Turgut Uygun; Selçuk Opan; Osman Karakaya
Journal:  Int J Clin Exp Med       Date:  2015-01-15

6.  Plasma calcidiol, calcitriol, and parathyroid hormone and risk of new onset heart failure in a population-based cohort study.

Authors:  Laura M G Meems; Frank P Brouwers; Michel M Joosten; Hiddo J Lambers Heerspink; Dick de Zeeuw; Stephan J L Bakker; Ron T Gansevoort; Wiek H van Gilst; Pim van der Harst; Rudolf A de Boer
Journal:  ESC Heart Fail       Date:  2016-04-26

7.  Dietary vitamin D and risk of heart failure in the Physicians' Health Study.

Authors:  Jeremy Robbins; Andrew B Petrone; J Michael Gaziano; Luc Djoussé
Journal:  Clin Nutr       Date:  2015-04-22       Impact factor: 7.324

8.  Secondary hyperparathyroidism is associated with pulmonary hypertension in older patients with chronic kidney disease and proteinuria.

Authors:  Gultekin Genctoy; Serap Arikan; Olcay Gedik
Journal:  Int Urol Nephrol       Date:  2014-12-24       Impact factor: 2.370

9.  Management of primary and renal hyperparathyroidism: guidelines from the German Association of Endocrine Surgeons (CAEK).

Authors:  T Weber; C Dotzenrath; H Dralle; B Niederle; P Riss; K Holzer; J Kußmann; A Trupka; T Negele; R Kaderli; E Karakas; F Weber; N Rayes; A Zielke; M Hermann; C Wicke; R Ladurner; C Vorländer; J Waldmann; O Heizmann; S Wächter; S Schopf; W Timmermann; D K Bartsch; R Schmidmaier; M Luster; K W Schmid; M Ketteler; C Dierks; P Schabram; T Steinmüller; K Lorenz
Journal:  Langenbecks Arch Surg       Date:  2021-04-21       Impact factor: 3.445

Review 10.  Phosphate imbalance in patients with heart failure.

Authors:  E C Christopoulou; T D Filippatos; E Megapanou; M S Elisaf; G Liamis
Journal:  Heart Fail Rev       Date:  2017-05       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.